Official registry condition

Hemorrhage peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Hemorrhage. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

2 profiles.

Registry update years

2008–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hemorrhage unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00369694

PeptideScanner retained ClinicalTrials.gov record NCT00369694 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-09-25, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
September 25, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01700478

PeptideScanner retained ClinicalTrials.gov record NCT01700478 at 2026-11-15T22:08:31.832Z. Its registry update date was 2013-02-11, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 11, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05958342

PeptideScanner retained ClinicalTrials.gov record NCT05958342 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 30, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →